A multicentre, randomised, double-blind, parallel-group, comparative study to compare the efficacy and safety of esomeprazole 20 mg once daily oral administration with omeprazole 10 mg and esomeprazole 10 mg once daily oral administration in maintenance treatment in patients with healed reflux esophagitis

Trial Profile

A multicentre, randomised, double-blind, parallel-group, comparative study to compare the efficacy and safety of esomeprazole 20 mg once daily oral administration with omeprazole 10 mg and esomeprazole 10 mg once daily oral administration in maintenance treatment in patients with healed reflux esophagitis

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Dec 2016

At a glance

  • Drugs Esomeprazole; Omeprazole
  • Indications Reflux oesophagitis
  • Focus Therapeutic Use
  • Sponsors AstraZeneca
  • Most Recent Events

    • 06 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Oct 2009 Actual end date (May 2009) added as reported by ClinicalTrials.gov.
    • 06 Oct 2009 Actual patient number (540) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top